questionsmedicales.fr
Mélanges complexes
Produits biologiques
Vaccins
Vaccins antiviraux
Vaccins antiviraux : Questions médicales fréquentes
Termes MeSH sélectionnés :
Tissue Plasminogen Activator
Diagnostic
5
Infections virales
Tests diagnostiques
Vaccins antiviraux
Tests sérologiques
Symptômes
Vaccins antiviraux
Efficacité des vaccins
Études cliniques
Symptômes
5
Symptômes
Vaccins antiviraux
Effets secondaires
Vaccins antiviraux
Infections virales
Effets secondaires
Types de vaccins
Réponse immunitaire
Infections virales
Symptômes
Prévention
5
Prévention
Vaccins antiviraux
Vaccins antiviraux
Grossesse
Souches virales
Vaccins antiviraux
Vaccination de masse
Immunité collective
Traitements
5
Vaccins antiviraux
Traitements antiviraux
Antiviraux
Infections virales
Vaccins antiviraux
Symptômes
Vaccination
Traitements antiviraux
Vaccins antiviraux
Prévention
Complications
5
Complications
Réactions allergiques
Complications
Vaccins antiviraux
Gestion des complications
Vaccins antiviraux
Profils de complications
Vaccins antiviraux
Facteurs de risque
5
Facteurs de risque
Infections virales
Antécédents médicaux
Vaccination
Voyages
Infections virales
Personnes âgées
Complications
Mode de vie
Infections virales
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vaccins antiviraux : Questions médicales les plus fréquentes",
"headline": "Vaccins antiviraux : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vaccins antiviraux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-24",
"dateModified": "2025-02-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vaccins antiviraux"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vaccins",
"url": "https://questionsmedicales.fr/mesh/D014612",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins",
"code": {
"@type": "MedicalCode",
"code": "D014612",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-adénovirus",
"alternateName": "Adenovirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D062705",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-adénovirus",
"code": {
"@type": "MedicalCode",
"code": "D062705",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.024"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le SIDA",
"alternateName": "AIDS Vaccines",
"url": "https://questionsmedicales.fr/mesh/D016915",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le SIDA",
"code": {
"@type": "MedicalCode",
"code": "D016915",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.050"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la COVID-19",
"alternateName": "COVID-19 Vaccines",
"url": "https://questionsmedicales.fr/mesh/D000086663",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la COVID-19",
"code": {
"@type": "MedicalCode",
"code": "D000086663",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.085"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin ChAdOx1 nCoV-19",
"alternateName": "ChAdOx1 nCoV-19",
"url": "https://questionsmedicales.fr/mesh/D000090985",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin ChAdOx1 nCoV-19",
"code": {
"@type": "MedicalCode",
"code": "D000090985",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.085.063"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ad26COVS1",
"alternateName": "Ad26COVS1",
"url": "https://questionsmedicales.fr/mesh/D000090984",
"about": {
"@type": "MedicalCondition",
"name": "Ad26COVS1",
"code": {
"@type": "MedicalCode",
"code": "D000090984",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.085.125"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le cytomégalovirus",
"alternateName": "Cytomegalovirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022482",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le cytomégalovirus",
"code": {
"@type": "MedicalCode",
"code": "D022482",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.120"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la dengue",
"alternateName": "Dengue Vaccines",
"url": "https://questionsmedicales.fr/mesh/D053059",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la dengue",
"code": {
"@type": "MedicalCode",
"code": "D053059",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.162"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la maladie à virus Ebola",
"alternateName": "Ebola Vaccines",
"url": "https://questionsmedicales.fr/mesh/D046129",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la maladie à virus Ebola",
"code": {
"@type": "MedicalCode",
"code": "D046129",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.205"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les herpèsvirus",
"alternateName": "Herpesvirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022283",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les herpèsvirus",
"code": {
"@type": "MedicalCode",
"code": "D022283",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin contre la varicelle",
"alternateName": "Chickenpox Vaccine",
"url": "https://questionsmedicales.fr/mesh/D019433",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre la varicelle",
"code": {
"@type": "MedicalCode",
"code": "D019433",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.130"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin contre le zona",
"alternateName": "Herpes Zoster Vaccine",
"url": "https://questionsmedicales.fr/mesh/D053061",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre le zona",
"code": {
"@type": "MedicalCode",
"code": "D053061",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.130.400"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccin contre le zona",
"alternateName": "Herpes Zoster Vaccine",
"url": "https://questionsmedicales.fr/mesh/D053061",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre le zona",
"code": {
"@type": "MedicalCode",
"code": "D053061",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.130.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les virus herpès simplex",
"alternateName": "Herpes Simplex Virus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022301",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les virus herpès simplex",
"code": {
"@type": "MedicalCode",
"code": "D022301",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la maladie de Marek",
"alternateName": "Marek Disease Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022501",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la maladie de Marek",
"code": {
"@type": "MedicalCode",
"code": "D022501",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins antigrippaux",
"alternateName": "Influenza Vaccines",
"url": "https://questionsmedicales.fr/mesh/D007252",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antigrippaux",
"code": {
"@type": "MedicalCode",
"code": "D007252",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.302"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre l'encéphalite japonaise",
"alternateName": "Japanese Encephalitis Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022321",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre l'encéphalite japonaise",
"code": {
"@type": "MedicalCode",
"code": "D022321",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.320"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin contre la rougeole",
"alternateName": "Measles Vaccine",
"url": "https://questionsmedicales.fr/mesh/D008458",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre la rougeole",
"code": {
"@type": "MedicalCode",
"code": "D008458",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.404"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antiourlien",
"alternateName": "Mumps Vaccine",
"url": "https://questionsmedicales.fr/mesh/D009108",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antiourlien",
"code": {
"@type": "MedicalCode",
"code": "D009108",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.488"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les papillomavirus",
"alternateName": "Papillomavirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D053918",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les papillomavirus",
"code": {
"@type": "MedicalCode",
"code": "D053918",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.498"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18",
"alternateName": "Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18",
"url": "https://questionsmedicales.fr/mesh/D000068857",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18",
"code": {
"@type": "MedicalCode",
"code": "D000068857",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.498.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les virus para-influenza",
"alternateName": "Parainfluenza Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022241",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les virus para-influenza",
"code": {
"@type": "MedicalCode",
"code": "D022241",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins antipoliomyélitiques",
"alternateName": "Poliovirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D023321",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antipoliomyélitiques",
"code": {
"@type": "MedicalCode",
"code": "D023321",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.623"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin antipoliomyélitique inactivé",
"alternateName": "Poliovirus Vaccine, Inactivated",
"url": "https://questionsmedicales.fr/mesh/D011054",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antipoliomyélitique inactivé",
"code": {
"@type": "MedicalCode",
"code": "D011054",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.623.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antipoliomyélitique oral",
"alternateName": "Poliovirus Vaccine, Oral",
"url": "https://questionsmedicales.fr/mesh/D011055",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antipoliomyélitique oral",
"code": {
"@type": "MedicalCode",
"code": "D011055",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.623.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la maladie d'Aujeszky",
"alternateName": "Pseudorabies Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022421",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la maladie d'Aujeszky",
"code": {
"@type": "MedicalCode",
"code": "D022421",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.632"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins antirabiques",
"alternateName": "Rabies Vaccines",
"url": "https://questionsmedicales.fr/mesh/D011819",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antirabiques",
"code": {
"@type": "MedicalCode",
"code": "D011819",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les virus respiratoires syncytiaux",
"alternateName": "Respiratory Syncytial Virus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022261",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les virus respiratoires syncytiaux",
"code": {
"@type": "MedicalCode",
"code": "D022261",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.730"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-rotavirus",
"alternateName": "Rotavirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022243",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-rotavirus",
"code": {
"@type": "MedicalCode",
"code": "D022243",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.760"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antirubéoleux",
"alternateName": "Rubella Vaccine",
"url": "https://questionsmedicales.fr/mesh/D012411",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antirubéoleux",
"code": {
"@type": "MedicalCode",
"code": "D012411",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.779"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin contre la rougeole, les oreillons et la rubéole",
"alternateName": "Measles-Mumps-Rubella Vaccine",
"url": "https://questionsmedicales.fr/mesh/D022542",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre la rougeole, les oreillons et la rubéole",
"code": {
"@type": "MedicalCode",
"code": "D022542",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.779.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le SIDA simien",
"alternateName": "SAIDS Vaccines",
"url": "https://questionsmedicales.fr/mesh/D018449",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le SIDA simien",
"code": {
"@type": "MedicalCode",
"code": "D018449",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.790"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antivariolique",
"alternateName": "Smallpox Vaccine",
"url": "https://questionsmedicales.fr/mesh/D012900",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antivariolique",
"code": {
"@type": "MedicalCode",
"code": "D012900",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.859"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les hépatites virales",
"alternateName": "Viral Hepatitis Vaccines",
"url": "https://questionsmedicales.fr/mesh/D014761",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les hépatites virales",
"code": {
"@type": "MedicalCode",
"code": "D014761",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.955"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-hépatite A",
"alternateName": "Hepatitis A Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022362",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-hépatite A",
"code": {
"@type": "MedicalCode",
"code": "D022362",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.955.395"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-hépatite B",
"alternateName": "Hepatitis B Vaccines",
"url": "https://questionsmedicales.fr/mesh/D017325",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-hépatite B",
"code": {
"@type": "MedicalCode",
"code": "D017325",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.955.400"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le virus du Nil occidental",
"alternateName": "West Nile Virus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D053060",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le virus du Nil occidental",
"code": {
"@type": "MedicalCode",
"code": "D053060",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.962"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antiamaril",
"alternateName": "Yellow Fever Vaccine",
"url": "https://questionsmedicales.fr/mesh/D022341",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antiamaril",
"code": {
"@type": "MedicalCode",
"code": "D022341",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.970"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antiviraux",
"alternateName": "Viral Vaccines",
"code": {
"@type": "MedicalCode",
"code": "D014765",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yukai Huang",
"url": "https://questionsmedicales.fr/author/Yukai%20Huang",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Xiao Guo",
"url": "https://questionsmedicales.fr/author/Xiao%20Guo",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Yuancheng Zhou",
"url": "https://questionsmedicales.fr/author/Yuancheng%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "Livestock and Poultry Biological Products Key Laboratory of Sichuan Province, Sichuan Animal Science Academy, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Dongying Liu",
"url": "https://questionsmedicales.fr/author/Dongying%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Jingrui Mao",
"url": "https://questionsmedicales.fr/author/Jingrui%20Mao",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy.",
"datePublished": "2022-09-03",
"url": "https://questionsmedicales.fr/article/36057550",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12886-022-02550-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "The LRP1/CD91 ligands, tissue-type plasminogen activator, α",
"datePublished": "2022-10-20",
"url": "https://questionsmedicales.fr/article/36266319",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-22498-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Site-specific PEGylation of recombinant tissue-type plasminogen activator.",
"datePublished": "2023-09-30",
"url": "https://questionsmedicales.fr/article/37783360",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejpb.2023.09.017"
}
},
{
"@type": "ScholarlyArticle",
"name": "Outcomes of asymptomatic recombinant tissue plasminogen activator associated intracranial hemorrhage.",
"datePublished": "2022-08-01",
"url": "https://questionsmedicales.fr/article/35913922",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0272257"
}
},
{
"@type": "ScholarlyArticle",
"name": "Glucocorticoid-Responsive Tissue Plasminogen Activator (tPA) and Its Inhibitor Plasminogen Activator Inhibitor-1 (PAI-1): Relevance in Stress-Related Psychiatric Disorders.",
"datePublished": "2023-02-24",
"url": "https://questionsmedicales.fr/article/36901924",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24054496"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Mélanges complexes",
"item": "https://questionsmedicales.fr/mesh/D045424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits biologiques",
"item": "https://questionsmedicales.fr/mesh/D001688"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vaccins",
"item": "https://questionsmedicales.fr/mesh/D014612"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vaccins antiviraux",
"item": "https://questionsmedicales.fr/mesh/D014765"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vaccins antiviraux - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vaccins antiviraux",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vaccins antiviraux",
"description": "Comment diagnostiquer une infection virale ?\nQuels tests sont utilisés pour les vaccins antiviraux ?\nLes symptômes indiquent-ils un besoin de vaccin ?\nComment évaluer l'efficacité d'un vaccin ?\nLes tests de dépistage sont-ils nécessaires avant vaccination ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Tissue+Plasminogen+Activator#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vaccins antiviraux",
"description": "Quels symptômes nécessitent un vaccin antiviral ?\nLes effets secondaires des vaccins sont-ils fréquents ?\nComment distinguer une infection d'un effet secondaire ?\nLes symptômes varient-ils selon le type de vaccin ?\nLes symptômes d'une infection virale sont-ils similaires ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Tissue+Plasminogen+Activator#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vaccins antiviraux",
"description": "Comment les vaccins antiviraux préviennent-ils les infections ?\nÀ quel âge doit-on commencer la vaccination antivirale ?\nLes vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?\nLes vaccins protègent-ils contre toutes les souches virales ?\nQuelle est l'importance de la vaccination de masse ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Tissue+Plasminogen+Activator#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vaccins antiviraux",
"description": "Les vaccins antiviraux sont-ils des traitements ?\nQuels traitements sont disponibles après infection ?\nLes vaccins peuvent-ils réduire la gravité des symptômes ?\nLes traitements sont-ils nécessaires après vaccination ?\nLes vaccins antiviraux nécessitent-ils des traitements préventifs ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Tissue+Plasminogen+Activator#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vaccins antiviraux",
"description": "Quelles complications peuvent survenir après vaccination ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications post-vaccinales ?\nLes complications varient-elles selon le vaccin ?\nLes complications peuvent-elles affecter l'immunité ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Tissue+Plasminogen+Activator#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vaccins antiviraux",
"description": "Quels sont les facteurs de risque pour les infections virales ?\nLes antécédents médicaux influencent-ils la vaccination ?\nLes voyages augmentent-ils le risque d'infection ?\nLes personnes âgées ont-elles plus de risques ?\nLe mode de vie influence-t-il le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Tissue+Plasminogen+Activator#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests virologiques, des analyses sanguines et des symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les vaccins antiviraux ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sérologiques et des cultures virales sont souvent utilisés pour évaluer l'immunité."
}
},
{
"@type": "Question",
"name": "Les symptômes indiquent-ils un besoin de vaccin ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fièvre ou la fatigue peuvent indiquer une infection nécessitant un vaccin."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un vaccin ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par des études cliniques et des taux d'infection dans la population vaccinée."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils nécessaires avant vaccination ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests peuvent être recommandés pour certaines populations à risque avant la vaccination."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un vaccin antiviral ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la toux, la fièvre ou des douleurs musculaires peuvent indiquer un besoin."
}
},
{
"@type": "Question",
"name": "Les effets secondaires des vaccins sont-ils fréquents ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires comme la douleur au site d'injection sont courants mais généralement légers."
}
},
{
"@type": "Question",
"name": "Comment distinguer une infection d'un effet secondaire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections présentent des symptômes persistants, tandis que les effets secondaires sont temporaires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de vaccin ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type de vaccin et la réponse immunitaire individuelle."
}
},
{
"@type": "Question",
"name": "Les symptômes d'une infection virale sont-ils similaires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses infections virales partagent des symptômes comme la fièvre et la fatigue."
}
},
{
"@type": "Question",
"name": "Comment les vaccins antiviraux préviennent-ils les infections ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils stimulent le système immunitaire à reconnaître et combattre les virus spécifiques."
}
},
{
"@type": "Question",
"name": "À quel âge doit-on commencer la vaccination antivirale ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge de vaccination dépend du vaccin, mais beaucoup commencent dès l'enfance."
}
},
{
"@type": "Question",
"name": "Les vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains vaccins sont sûrs pendant la grossesse, mais il est essentiel de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Les vaccins protègent-ils contre toutes les souches virales ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccins ciblent des souches spécifiques, et des mises à jour peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de la vaccination de masse ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination de masse aide à atteindre l'immunité collective et à réduire la propagation des virus."
}
},
{
"@type": "Question",
"name": "Les vaccins antiviraux sont-ils des traitements ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccins préviennent les infections, tandis que les traitements ciblent les infections existantes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles après infection ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antiviraux comme l'oseltamivir peuvent être prescrits pour traiter certaines infections virales."
}
},
{
"@type": "Question",
"name": "Les vaccins peuvent-ils réduire la gravité des symptômes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins peuvent atténuer la gravité des symptômes en cas d'infection post-vaccination."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils nécessaires après vaccination ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas nécessairement, mais des traitements peuvent être requis si une infection survient malgré la vaccination."
}
},
{
"@type": "Question",
"name": "Les vaccins antiviraux nécessitent-ils des traitements préventifs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccins sont une mesure préventive, mais des traitements peuvent être nécessaires en cas d'exposition."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après vaccination ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications rares incluent des réactions allergiques sévères ou des syndromes neurologiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la plupart des complications sont rares et les bénéfices de la vaccination l'emportent sur les risques."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications post-vaccinales ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter un professionnel de santé pour évaluer et traiter les complications éventuelles."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le vaccin ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque vaccin peut avoir des profils de complications différents selon sa composition."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter l'immunité ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent temporairement affecter la réponse immunitaire, mais cela est rare."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les infections virales ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, les maladies chroniques, et l'immunodépression."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils la vaccination ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de réactions allergiques ou de maladies peuvent influencer le choix du vaccin."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones à risque peut augmenter l'exposition à des virus spécifiques."
}
},
{
"@type": "Question",
"name": "Les personnes âgées ont-elles plus de risques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées sont plus susceptibles de développer des complications graves liées aux infections."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'infection ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain, incluant une bonne nutrition et de l'exercice, peut réduire le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 18/02/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Livestock and Poultry Biological Products Key Laboratory of Sichuan Province, Sichuan Animal Science Academy, Chengdu, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutics, School of Pharmacy, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Hematology, College of Pharmacy, Army Medical University (Third Military Medical University), Chongqing, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Provincial Department of Education, Key Laboratory of Infectious Disease & Bio-Safety, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Centre for Virus and Vaccine Research, Sunway University, Bandar Sunway, Malaysia.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. dailp@im.ac.cn.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
McMaster Immunology Research Centre and Department of Medicine, McMaster University, Hamilton, ON L8S 4K1, Canada. Electronic address: xingz@mcmaster.ca.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
, Rockville, MD, USA. halsteads@erols.com.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: Naina.mccann@paediatrics.ox.ac.uk.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Department of Chemical Sciences, University of Naples Federico II, Naples, Italy; GSK, Siena, Italy.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Department of Chemical Sciences, University of Naples Federico II, Naples, Italy.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Department of Chemical Sciences, University of Naples Federico II, Naples, Italy. Electronic address: cristina.decastro@unina.it.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Publications dans "Vaccins antiviraux" :
Diabetic retinopathy (DR) is a serious complication of longstanding type 2 diabetes mellitus (T2DM), a leading cause of blindness and visual disability in the world. The aim of this study is to compar...
Among the T2DM patients enrolled in this study, 26 patients had DR (n = 26) while 29 were without DR (n = 29). The blood and tear samples were obtained from all participants. The level of PAI-1 and tP...
Patients with DR had significantly longer disease duration and higher systolic blood pressure compared to those without DR. Serum PAI-1 level was significantly higher in patients with DR compared to t...
The present study demonstrated a significantly greater serum PAI-1 levels in patients with DR compared to those without DR. No significant correlations between tears and serum PAI-1 and tPA were obser...
LDL Receptor-related Protein-1 (LRP1/CD91) binds diverse ligands, many of which activate cell-signaling. Herein, we compared three LRP1 ligands that inhibit inflammatory responses triggered by lipopol...
Tissue-type plasminogen activator (tPA) is the gold standard for emergency treatment of ischemic stroke, which is the third leading cause of death worldwide. Major challenges of tPA therapy are its ra...
Intracranial hemorrhage (ICH) is the most devastating complication of recombinant tissue plasminogen activator (rtPA) treatment in acute ischemic stroke patients. Data on rtPA-associated asymptomatic ...
To determine the incidence, risk factors, characteristics, management, and clinical outcome of rtPA-associated aICH....
The data were retrieved from the Chiang Mai University Hospital Stroke Registry between 1995 and 2019. Consecutive ischemic stroke patients were included if they were 18 or older and received rtPA. St...
Of 725 rtPA treated patients, 166 (16.0%, 95% confidence interval [CI] 13.4-18.9) had aICH, 50 (6.9%, 95% CI 5.2-9.0) had symptomatic ICH (sICH). Patients with aICH had more hemorrhagic infarctions (H...
The rtPA-associated aICH increased the risk of morbidity and mortality outcomes. Further treatment consensus, guideline generation, or clinical trials focusing on the treatment of rtPA-associated aICH...
Stressful events trigger a set of complex biological responses which follow a bell-shaped pattern. Low-stress conditions have been shown to elicit beneficial effects, notably on synaptic plasticity to...
Fibrinolytic therapy can be effective for management of complex pleural effusions. Tissue plasminogen activator (tPA, 10 mg) and deoxyribonuclease (DNAse) every 12 h with a dwell time of one hour is a...
Charts were reviewed and demographics, clinical data and treatment information were abstracted. Outcomes were assessed based on radiographic findings and need for surgery....
Two hundred and fifteen effusions in 207 patients (8 bilateral) were identified. 85% were either infectious or malignant. Two hundred and forty nine chest tubes were used: 84% were 10 Fr or 12 Fr and ...
Low dose tPA daily with a 12 h dwell time may be as effective as the standard regimen of tPA and DNAse twice daily with one hour dwell. For most patients only three doses were required, and small pigt...
The neurovascular unit (NVU) is assembled by endothelial cells (ECs) and pericytes, and encased by a basement membrane (BM) surveilled by microglia and surrounded by perivascular astrocytes (PVA), whi...
Respiratory system involvement is common in congenital plasminogen deficiency. Although many treatment approaches have been tried, there is still no definitive treatment for respiratory system involve...
We report 2 congenital plasminogen deficiency cases, who presented with severe respiratory symptoms, for whom a novel treatment modality was tried. After intravenous administration of FFP (fresh froze...
Intratracheal administration of tissue plasminogen activator and FFP is an available treatment modality for patients with lung involvement. Fibrin plaques should be carefully removed and new lesion fo...
Ischemic stroke is relatively rare in children, leading to a low level of suspicion and delayed diagnosis, particularly in cases of posterior circulation occlusion when symptoms are less indicative. O...
We report a case of a 16-year-old male who presented to the pediatric emergency department with altered mental status. There was no history of trauma or intoxication. The main symptoms included confus...
The most severe complication associated with giant coronary aneurysm in children with Kawasaki disease is ischemic cardiomyopathy (ICM) caused by thrombosis. Addition of tissue plasminogen activator, ...
Total four male KD patients with central thromboses in coronary aneurysm were treated in Pediatric Cardiology Department of Shengjing Hospital, China Medical University, from January 2020 to August 20...
4 young male KD patients had coronary aneurysm (CAA) complicated with total 7 occurrences of central thrombosis. These patients were given alteplase and heparin/oral Warfarin + Aspirin + Clopidogrel t...
1. Pediatric KD patients complicated with coronary aneurysm thrombosis are prone to recurrence of thrombosis. 2. In KD patients complicated with coronary aneurysm thrombosis, treatments described in M...